NEW YORK (
CHANGE IN RATINGS
(AAPL - Get Report)
was initiated with a buy rating at Citigroup. $675 price target. Risks are increasingly in focus, Citi said.
(ARO - Get Report)
was downgraded at Janney Montgomery from buy to neutral. $14 price target. Company may lose near-term market share to ANF and AEO, Janney Montgomery said.
was initiated with a neutral rating at UBS. $9.50 price target. Solid foundation, but some "show me" is warranted, UBS said.
(BRCM - Get Report)
was upgraded at Benchmark from hold to buy. Company can gain market share and generate solid organic growth in the coming quarters, Benchmark said.
was downgraded at FBR Capital Markets from outperform to market perform. $18 price target. Valuation call, as the stock is up 68% year to date, FBR said.
(DNKN - Get Report)
was initiated with a buy rating at UBS. $36 price target. Competitive insulation and innovation, UBS said.
was upgraded at Keybanc from hold to buy. $81 price target. Estimates also boosted, as the company is opening more stores and can realize higher margins, Keybanc said.
(EXC - Get Report)
was upgraded at Deutsche Bank to buy. $34 price target. Valuation call, as the stock is down 20% over the past month, Deutsche Bank said. Shares are already pricing in a potential dividend cut, Deutsche added.
was downgraded to hold at TheStreet Ratings.
was downgraded at Robert Baird from outperform to neutral. $54 price target. Company faces more near-term challenges, Robert Baird said.
was initiated with an outperform rating at Credit Suisse. $50 price target. Demand growth should outpace supply in 2013, Credit Suisse said.
was downgraded to sell at TheStreet Ratings.
was downgraded at Bank of America/Merrill Lynch to underperform. $13 price target. Company is facing slower industry growth and increased pricing pressure, BofA/Merrill said.
STOCK COMMENTS / EPS CHANGES
estimates were raised at Jefferies through 2013. Sales productivity should see a more significant improvement ramp, Jefferies said. Buy rating.
numbers were cut at UBS. Shares are now seen reaching $96. Estimates were also lowered to reflect higher interest expense, UBS said. Buy rating.